Series B - ZetaGen Therapeutics
Investment Firm
Overview
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.
Announced Date
Aug 11, 2023
Closed on Date
Aug 11, 2023
Funding Type
Series B
Highlights
Location
New York, United States, North America
Social
Participant Investors
2
| Investor Name |
|---|
 Consolidated Investment Group |
Round Details and Background
ZetaGen Therapeutics raised $9790000 on 2023-08-11 in Series B
ZetaGen Therapeutics commercializes a small molecule-based osteoinductive platform.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jun 12, 2018 |  Seed Round - ZetaGen Therapeutics | 1 | - | undefined |
| Dec 13, 2021 | Grant - ZetaGen Therapeutics | 1 | - | 2.0M |
| Oct 20, 2022 | Series B - ZetaGen Therapeutics | 1 | - | undefined |
| Aug 11, 2023 | Series B - ZetaGen Therapeutics | 2 | - | 9.8M |
Recent Activity
There is no recent news or activity for this profile.